2023 ANA Symposium Frequently Asked Questions

What is the 2023 Aniridia North America Symposium: PAX6, Aniridia, and Beyond?

This meeting, like its predecessor, the 2021 Aniridia North America Symposium: PAX6, Aniridia, and Beyond, will provide a forum for the scientific community to present current PAX6 and aniridia research findings and facilitate collaboration on future studies. Sessions will cover topics from all aspects of the research spectrum, from basic science to clinical care. This will include sessions on glaucoma, corneal health, genetics, eye development, and research methods. Many of the sessions will share research results that are not yet published.

When is this symposium?

This meeting will be held September 29-October 2 at the University of Virginia in Charlottesville. 

What is the format of this meeting?

This conference is for scientists by scientists, with presentations and roundtable discussions presented to each other using high-level scientific details and language.  

Poster showing the Patient Community Representatives that will attend the 2023 ANA Symposium.  The list includes:  

Grayson Chinn - VFT, ANA PFAB
Suzanne Chinn - VFT
Janelle Collins, ANA
Adison Lemmon, ANA PFAB
John Morris, IWSA, Miranda's Mission
Micjael and Bobbi Schain - ANA PFAB
Kelly Trout - IWSA and ANA
Susan Wolfe - VFT and ANA
Matt Wolfe - VFT

Who will attend this conference?

An international group of 25-30 researchers have committed to attend this conference.

The ANA Board of Directors will also be in attendance as will many members of the ANA Patient and Family Advisory Board.  Additionally, leaders of related advocacy organizations have been invited to represent the aniridia patient community and share important news emanating from the symposium.   

The poster to the left shows a list of some of the patient community representatives that will be in attendance, along with their affiliated organizations.

How will ANA share important news that emanates from the symposium?

ANA plans to report live from the symposium via the ANA Facebook page. Documents also will be created post-conference that will give further information to the patient community and/or the scientific community.

What was discussed at the 2021 ANA Symposium?

After the 2021 Aniridia North America Symposium: PAX6, Aniridia, and Beyond, the ANA board created two documents for distribution to the public.

The first document, “Overview of Themes for the Patient Community” was published in early 2022 on the ANA website, giving a plain language overview of each speaker’s presentation.

The second document, “Report on the 2021 Aniridia North America symposium on PAX6, aniridia, and beyond“, was published in the “The Ocular Surface” journal in July of 2023, giving a higher level scientific summary of the presentations.

Who is funding the symposium?

This meeting is made possible by generous funding and support from the University of Virginia, Vision for Tomorrow, the University of Georgia, the Delta Gamma Foundation, the International WAGR Syndrome Association, and Miranda’s Mission.

Leave a Comment

Logo - Outline of an eye, with ANA in the middle and Aniridia North America underneath

Aniridia North America
106 W. Calendar Ave
Suite 122
LaGrange, IL 60525

Aniridia North America is registered as a 501(c)(3) non-profit organization in the United States.

EIN: 86-2917141

Resize text-+=